• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Trial Recovery Requires More Technology Support from Sponsors/CROs, Sites Say

Trial Recovery Requires More Technology Support from Sponsors/CROs, Sites Say

July 20, 2020

Site staff believe more telecommunication technology will be needed to get trials back on their feet post-pandemic and say they need help from sponsors and CROs to implement alternative approaches to in-person patient visits, according to a new report.

Respondents to a survey conducted by Clinical SCORE said it will take 5 to 6 months on average to recover from financial losses and return the number of trials being activated to pre-COVID-19 levels. Financial recovery will require scaling up remote and virtual visits to make up for loss of staff during the pandemic.

Most of the 255 survey respondents expect the number of in-person site visits to decline, and 62 percent said telephone communications will see the greatest increase, followed by virtual visits (e.g., web-based video visits) at 51 percent and remote visits conducted at facilities other than the trial sites at 47 percent. Home visits also will increase, according to 20 percent of respondents.

Three-quarters of respondents said they need more support from sponsors for the protocol changes required to implement virtual and remote visits as well as funding to do so. One-third called for CRO assistance in executing remote visits.

To read the report, click here: https://bit.ly/32s8ZBR.

COVID-19
  • Related Directories

    Olumiant (baricitinib)

    Veklury (remdesivir)

    Comirnaty (COVID-19 Vaccine, mRNA)

Upcoming Events

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing